Is CeriBell, Inc. (CBLL) a Buy, Sell, or Hold?
CeriBell, Inc.
NASDAQ:CBLL
$19.13 USD
-$0.39 (-2.0%)
- Volume
- 387.15K
- Average Volume
- 331.06K
- Market Capitalization
- $725.84M
- P/E Ratio
- -11.74
- Dividend Yield
- 0.00%
- Price Target
- $25.00
- Year High
- $24.33
- Year Low
- $10.85
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.30
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Xingjuan Chao |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Current Symbol | CBLL |
| CUSIP | 15678C102 |
| CIK | 0001861107 |
| Web | https://ceribell.com |
| Phone | 800 436 0826 |
| Currency | USD |
| Employees | 327 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.16 |
| Payout Ratio | 0.00 |
| Current Ratio | 10.30 |
| Quick Ratio | 9.87 |
| Cash Ratio | 2.80 |
Sales & Book Value
| Annual Sales | $89.06M |
| Price / Sales | 7.64 |
| Cash Flow | -1.33 |
| Price / Cash Flow | -14.47 |
| Price / Book | 5.12 |
Price Target and Rating
| Average Stock Price Forecast | $25.00 |
| High Stock Price Forecast | $25.00 |
| Low Stock Price Forecast | $25.00 |
| Forecast Upside/Downside | -23.48% |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 4 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-1.46 |
| Trailing P/E Ratio | -11.74 |
| PEG Ratio | -0.43 |
| P/E Growth | -0.43 |
| Net Income | $-53.41M |
| Net Margin | -63.51% |
| Pretax Margin | -63.51% |
| Return on Equity | -38.19% |
| Return on Assets | -33.90% |
Financials Score
| AltmanZ Score | 10.64 |
| Piotroski Score | 1.00 |
| Working Capital | 150.5M |
| Total Assets | 178.08M |
| Ebit | -58.52M |
| Market Cap | 748.99M |
| Total Liabilities | 37.26M |
Poll Results
About CeriBell, Inc. (NASDAQ:CBLL) Stock
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California. ...
2026-06-08 07:00:00
Study published in leading critical care journal shows that higher AI-detected seizure burden is associated with increased odds of disability, further demonstrating the utility of the Ceribell System as a clinical decision-making tool Study published in leading critical care journal shows that higher AI-detected seizure burden is associated with increased odds of disability, further demonstrating the utility of the Ceribell System as a clinical decision-making tool
Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference
2026-05-20 16:05:00
SUNNYVALE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present at the upcoming William Blair 46th Annual Growth Stock Conference in Chicago. The presentation will take place on Wednesday, June 3, 2026, at 9:20 a.m. Pacific Daylight Time / 11:20 a.m. Central Daylight Time.
CeriBell Sees ‘Early Innings' Growth as Hospital Accounts and Usage Hit Records
2026-05-15 01:07:14
CeriBell NASDAQ: CBLL executives said the company's first-quarter results reflected continued momentum in both new account additions and increased usage among existing hospital customers, while outlining early progress in new clinical areas including neonatal seizure monitoring and delirium.
CeriBell, Inc. (CBLL) Presents at Bank of America Global Healthcare Conference 2026 Transcript
2026-05-13 20:50:43
CeriBell, Inc. (CBLL) Presents at Bank of America Global Healthcare Conference 2026 Transcript
CeriBell, Inc. (CBLL) Q1 2026 Earnings Call Transcript
2026-05-12 09:10:43
CeriBell, Inc. (CBLL) Q1 2026 Earnings Call Transcript
CeriBell Q1 Earnings Call Highlights
2026-05-11 19:07:47
CeriBell NASDAQ: CBLL reported first-quarter revenue growth of 29% and raised its full-year outlook, as management cited higher usage of its seizure monitoring system and the company's strongest quarter of net new hospital additions since becoming public.
CeriBell, Inc. (CBLL) Reports Q1 Loss, Beats Revenue Estimates
2026-05-11 19:06:31
CeriBell, Inc. (CBLL) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to a loss of $0.36 per share a year ago.
Ceribell Reports First Quarter 2026 Financial Results
2026-05-11 16:05:00
SUNNYVALE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financial results for the first quarter ended March 31, 2026.
Frequently Asked Questions
-
What is the current CeriBell, Inc. (CBLL) stock price?
-
CeriBell, Inc.(NASDAQ:CBLL) stock price is $19.13 in the last trading session. During the trading session, CBLL stock reached the peak price of $24.33 while $10.85 was the lowest point it dropped to. The percentage change in CBLL stock occurred in the recent session was --2.0% while the dollar amount for the price change in CBLL stock was -$-0.39.
-
CBLL's industry and sector of operation?
-
The NASDAQ listed CBLL is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of CBLL?
-
David Foehr | Senior Vice President of Finance
Josef Parvizi | Co-Founder, Chief Medical Advisor & Director
Raymond Woo | Chief Technology Officer
Xingjuan Chao | Co-Founder, President, Chief Executive Officer & Director
Brian Price | Senior Vice President of Marketing -
How many employees does CBLL have?
-
Number of CBLL employees currently stands at 327. CBLL operates from 360 North Pastoria Avenue, Sunnyvale, CA 94085, US.
-
Link for CBLL official website?
-
Official Website of CBLL is: https://ceribell.com
-
How do I contact CBLL?
-
CBLL could be contacted at phone #800 436 0826 and can also be accessed through its website. CBLL operates from 360 North Pastoria Avenue, Sunnyvale, CA 94085, US.
-
How many shares of CBLL are traded daily?
-
The average number of CBLL shares traded daily for last 3 months was 331.06K.
-
What is the market cap of CBLL currently?
-
The market value of CBLL currently stands at $725.84M with its latest stock price at $19.13